ANWITA BIOSCIENCES
Anwita Biosciences involves the discovery and development of optimized immunotherapeutics, leveraging core expertise in cancer immunotherapy, bioinformatics, and target-based protein evolution. Their products include half-live extended Exenokines, immune cell- or tumor cell-targeting Mableukines, and bi-functional Duoleukins. Their new generation of cytokines could serve as immune therapy with a range of applications in treating patients with cancers and autoimmune diseases.
ANWITA BIOSCIENCES
Social Links:
Industry:
Bioinformatics Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.anwitabio.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 600 9828
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Maps SSL By Default HSTS IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aposcience AG
Aposcience AG is a biopharmaceutical company.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Matrix Biomed
Matrix Biomed is a biopharmaceutical company.
NeuroTrauma Sciences
NeuroTrauma Sciences is a biopharmaceutical company.
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
SignaBlok
SignaBlok is a biopharmaceutical company.
Xoc Pharmaceuticals
Xoc Pharmaceuticals is a biopharmaceutical company.
Official Site Inspections
http://www.anwitabio.com Semrush global rank: 9.14 M Semrush visits lastest month: 445
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Anwita Biosciences"
Anwita Biosciences Inc.
Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company headquartered in the San Francisco Bay Area. Our mission is to deliver transformative treatment options to improve the โฆSee details»
Anwita Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 650 600 9828 Anwita Biosciences involves the discovery and development of optimized โฆSee details»
Company Information - RocketReach
Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company headquartered in the San Francisco Bay Area. We are advancing our product pipeline of improved cytokines โฆSee details»
Anwita Biosciences Company Profile | Management and
[email protected]: Anwita Biosciences Top Competitors. Company Employees Revenue Top technologies; Cellectar Biosciences. 12: $3.8 M: REGiMMUNE Corp. 10: $1.9 M: Revitope โฆSee details»
Anwita Biosciences - Overview, News & Similar companies
Who is Anwita Biosciences. Anwita Biosciences, Inc. is an emerging biopharmaceutical company headquartered in the San Francisco Bay Area. Our mission is to deliver transforma tive โฆSee details»
ANWITA BIOSCIENCES INC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANWITA BIOSCIENCES INC of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Anwita Biosciences, Inc. Company Profile - Dun & Bradstreet
Anwita Biosciences, Inc. Company Profile | Belmont, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Anwita Biosciences Inc | LinkedIn
Anwita Biosciences Inc Biotechnology Research San Carlos, California 191 followers Anwita Biosciences, Inc. is an emerging biopharmaceutical company headquartered in the San โฆSee details»
Anwita Biosciences Inc. Details
Website Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company based in the San Francisco Bay Area. Specializing in the discovery and development of optimized โฆSee details»
Anwita Biosciences - PitchBook
Anwita Biosciences General Information Description. Developer of antibodies designed to deliver transformative treatment options for cancer and autoimmune diseases. The company specializes in the discovery and development of โฆSee details»
Anwita Biosciences, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Anwita Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Neoplasms, Immune System Diseases ...See details»
Anwita Biosciences | VentureRadar
Website: https://anwitabio.com/ Develops advanced biopharmaceutical products using structure-guided AccuKine cytokine evolution and AccuBody discovery for treating ...See details»
Anwita Biosciences Inc Overview - Salary.com
Discover essential details about Anwita Biosciences Inc, including address, contact, and journey of our company's evolution.See details»
Anwita Biosciences, Inc.:Company Profile & Technical Research ...
Feb 13, 2023 Anwita Biosciences, Inc. is a company that provides Immune therapy, Cancer immunotherapy, Biopharmaceutical and more. Anwita Biosciences, Inc. is headquartered in โฆSee details»
Anwita Biosciences - Company Profile - Tracxn
Nov 27, 2024 Anwita Biosciences - Developer of transformative treatment options for cancer and autoimmune diseases. Anwita Biosciences has 3023 competitors.See details»
Anwita Biosciences, Inc. (Anwita Biosciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
ไบ่งฃAnwita Biosciences, Inc. (Anwita Biosciences, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็2้กนไธดๅบ่ฏ้ช, 4็ฏๆฐ้ปๅ1็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผ่กๆถฒๅๆทๅทด็ณป็ป็พ็ ๏ผๅ ็ซ็ณป โฆSee details»
A Safe and Highly Potent ฮฑPD1-IL2 Fusion (AWT020) that โฆ
[email protected] [email protected] 300IndustrialRd.SanCarlos,CA94070 INTRODUCTION Interleukin 2 (IL-2) is one of the most โฆSee details»
Anwita Biosciences - VentureRadar
Similar Companies: Shanghai Junshi Biosciences China Listed Junshi Bio is an innovation-driven biopharmaceutical company, committed to the discovery and development of innovative drugs, โฆSee details»
October 5 , 2022 - Anwita Bio
FOR IMMEDIATE RELEASE . October 5. th, 2022. Anwita Biosciences, Inc. Multiple Poster PresentationAnnounces s Showcasing Its Three Cytokine-Based Therapeutics at 37See details»
FOR IMMEDIATE RELEASE - Anwita Bio
FOR IMMEDIATE RELEASE March 15th, 2022 Anwita Biosciences, Inc. Announces Upcoming Late-Breaking Poster Presentation on the Preclinical Development of Mableukine-2PD1 at โฆSee details»